scPharmaceuticals Inc. (SCPH)
5.67
0.00 (0.00%)
Inactive · Last trade price on Oct 6, 2025
scPharmaceuticals Revenue
scPharmaceuticals had revenue of $16.04M in the quarter ending June 30, 2025, with 99.17% growth. This brings the company's revenue in the last twelve months to $49.97M, up 107.79% year-over-year. In the year 2024, scPharmaceuticals had annual revenue of $36.33M with 167.28% growth.
Revenue (ttm)
$49.97M
Revenue Growth
+107.79%
P/S Ratio
5.89
Revenue / Employee
$304,689
Employees
164
Market Cap
304.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36.33M | 22.74M | 167.28% |
| Dec 31, 2023 | 13.59M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSCPH News
- 6 weeks ago - SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH - Business Wire
- 2 months ago - MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases - GlobeNewsWire
- 2 months ago - scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111 - GlobeNewsWire
- 2 months ago - scPharmaceuticals Inc. (SCPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025 - GlobeNewsWire
- 5 months ago - scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha
- 6 months ago - scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript - Seeking Alpha